Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)

SHA:688217 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,321	1,018	1,999	1,965	4,042	-
Market Cap Growth	-24.63%	-49.08%	1.72%	-51.39%	-	-
Enterprise Value	1,112	835	1,790	1,692	3,916	-
Last Close Price	23.94	18.44	35.78	35.19	72.39	-
PE Ratio	-	-	252.00	48.54	85.39	-
Forward PE	95.76	76.83	41.61	-	-	-
PS Ratio	5.67	4.20	7.74	4.63	13.89	-
PB Ratio	1.43	1.11	2.07	2.02	4.51	-
P/TBV Ratio	1.53	1.19	2.30	2.27	5.08	-
P/FCF Ratio	61.76	49.48	-	-	-	-
P/OCF Ratio	22.39	16.97	44.32	26.89	51.84	-
EV/Sales Ratio	4.77	3.45	6.93	3.99	13.46	-
EV/EBITDA Ratio	41.20	40.23	61.41	16.32	65.23	-
EV/EBIT Ratio	-	-	-	23.24	144.85	-
EV/FCF Ratio	51.98	40.60	-	-	-	-
Debt / Equity Ratio	0.01	0.02	0.03	0.01	0.01	0.00
Debt / EBITDA Ratio	0.17	0.93	0.85	0.13	0.15	0.01
Debt / FCF Ratio	0.22	1.09	-	-	-	0.02
Asset Turnover	0.23	0.24	0.24	0.42	0.35	0.42
Inventory Turnover	1.23	1.21	1.23	3.65	2.45	2.56
Quick Ratio	9.08	10.73	10.17	6.17	14.85	8.27
Current Ratio	10.68	12.14	11.97	6.93	16.64	10.37
Return on Equity (ROE)	-2.42%	-2.74%	-0.50%	7.06%	5.14%	6.11%
Return on Assets (ROA)	-1.03%	-1.18%	-0.59%	4.48%	2.04%	3.48%
Return on Capital (ROIC)	-1.09%	-1.23%	-0.64%	4.81%	2.15%	3.75%
Return on Capital Employed (ROCE)	-	-	-	7.30%	3.00%	5.70%
Earnings Yield	-0.98%	-1.55%	0.40%	2.06%	1.17%	-
FCF Yield	1.62%	2.02%	-3.20%	-1.70%	-0.44%	-
Dividend Yield	-	-	0.50%	-	-	-
Payout Ratio	-	-	131.08%	0.03%	0.04%	-
Buyback Yield / Dilution	-5.78%	0.61%	-2.17%	-11.28%	-19.69%	0.12%
Total Shareholder Return	-5.78%	0.61%	-1.67%	-11.28%	-19.69%	0.12%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.